OptimizeRx Corporation - Laporan Laba Rugi (TTM)

OptimizeRx Corporation
US ˙ NasdaqCM ˙ US68401U2042

Laporan Laba Rugi (TTM)

Laporan Laba Rugi OptimizeRx Corporation menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 34 43 47 52 57 61 64 64 63 62 62 62 63 72 78 83 88 92 94 105
Change (%) 26.40 8.41 10.31 10.82 6.77 4.08 0.55 -1.62 -1.04 -1.17 -0.26 2.02 13.88 9.35 6.39 5.98 4.48 2.43 11.00
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 14 19 21 23 26 26 26 26 24 23 23 24 25 29 31 32 33 33 34 37
Change (%) 34.39 9.70 9.22 11.05 0.39 2.05 -2.26 -5.41 -2.98 -0.25 4.29 3.55 13.16 6.69 3.65 4.20 -0.71 3.35 10.20
% of Revenue 41.71 44.35 44.87 44.43 44.52 41.86 41.04 39.89 38.35 37.60 37.95 39.68 40.27 40.02 39.05 38.04 37.41 35.55 35.87 35.61
Gross Operating Profit 20 24 26 29 32 36 38 39 39 39 38 37 38 43 48 52 55 59 61 67
Change (%) 20.68 7.39 11.20 10.64 11.89 5.55 2.51 0.89 0.16 -1.72 -3.04 1.02 14.36 11.12 8.13 7.07 7.58 1.92 11.45
% of Revenue 58.29 55.65 55.13 55.57 55.48 58.14 58.96 60.11 61.65 62.40 62.05 60.32 59.73 59.98 60.95 61.96 62.59 64.45 64.13 64.39
SG&A 22 23 23 26 30 33 39 43 46 49 52 52 52 54 56 58 59 61 59 59
Change (%) 5.32 0.20 10.94 16.07 10.15 16.54 11.16 7.12 6.90 5.36 -0.28 0.57 3.31 3.97 3.94 0.76 4.68 -2.94 -0.01
% of Revenue 64.71 53.92 49.83 50.12 52.49 54.15 60.63 67.03 72.98 78.84 84.05 84.03 82.83 75.15 71.45 69.81 66.37 66.50 63.01 56.76
R&D
Change (%)
% of Revenue
OpEx 39 45 47 50 56 61 67 72 74 75 77 78 79 85 89 93 96 98 98 101
Change (%) 15.74 4.23 7.49 12.38 8.42 9.83 7.17 3.06 1.12 3.44 0.97 1.42 7.08 5.49 4.39 2.57 2.70 -0.69 3.53
% of Revenue 112.55 103.06 99.08 96.54 97.90 99.41 104.90 111.81 117.12 119.68 125.26 126.80 126.05 118.53 114.34 112.20 108.59 106.75 103.50 96.53
Operating Income -4 -1 0 2 1 0 -3 -8 -11 -12 -16 -17 -16 -13 -11 -10 -8 -6 -3 4
Change (%) -69.21 -132.79 312.69 -32.67 -70.07 -965.84 142.23 42.67 13.75 26.86 5.82 -0.83 -19.02 -15.35 -9.51 -25.36 -17.93 -46.89 -210.12
% of Revenue -12.55 -3.06 0.92 3.46 2.10 0.59 -4.90 -11.81 -17.12 -19.68 -25.26 -26.80 -26.05 -18.53 -14.34 -12.20 -8.59 -6.75 -3.50 3.47
Interest Expense -1 -3 -5 -6 -6 -6 -6
Change (%) 106.33 50.93 33.63 1.81 -4.04 1.25
% of Revenue -2.03 -3.84 -5.44 -6.86 -6.69 -6.26 -5.71
Net Income -6 -2 -1 1 1 0 -3 -7 -10 -11 -14 -14 -14 -18 -18 -18 -24 -20 -15 -10
Change (%) -60.23 -70.98 -223.17 40.91 -65.99 -826.21 154.31 50.22 9.05 23.05 1.96 -4.19 27.75 2.85 -0.84 34.94 -16.81 -23.37 -35.96
% of Revenue -16.19 -5.10 -1.36 1.52 1.94 0.62 -4.30 -10.88 -16.62 -18.32 -22.80 -23.31 -21.89 -24.56 -23.10 -21.53 -27.41 -21.83 -16.33 -9.42

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista